For covariates, we used four clinical covariates (age, ER, PR, and HER2 status) that are routinely used in breast cancer treatment decisions and the expression levels of 96 genes implicated in modifying chemotherapy effects (eg BRCA1/2) (Sotiriou and Pusztai 2009). The gene discussed is ERBB2; the disease is breast carcinoma.